Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep.
暂无分享,去创建一个
[1] G. Laurent,et al. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis. , 1984, Collagen and related research.
[2] E. Engvall,et al. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen , 1977, International journal of cancer.
[3] M. Rola-Pleszczynski,et al. Computer-based quantitative analysis of gallium-67 uptake in normal and diseased lungs. , 1983, Chest.
[4] A. Cantin,et al. Airway function in lifetime-nonsmoking older asbestos workers. , 1983, The American journal of medicine.
[5] M. Rola-Pleszczynski,et al. Sequential analysis of the bronchoalveolar milieu in conscious sheep. , 1981, Journal of applied physiology: respiratory, environmental and exercise physiology.
[6] M. Rola-Pleszczynski,et al. Asbestos exposure enhances the release of fibroblast growth factor by sheep alveolar macrophages. , 1983, Journal of the Reticuloendothelial Society.
[7] G. Laurent,et al. Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. , 1984, Thorax.
[8] R. Bégin,et al. Morphologic features and function of the airways in early asbestosis in the sheep model. , 1982, The American review of respiratory disease.
[9] M. Turner-Warwick,et al. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. , 1983, Thorax.
[10] J. Savory,et al. Manual nephelometric methods for immunochemical determination of immunoglobulins IgG, IgA, and IgM in human serum. , 1972, Clinical chemistry.
[11] M. Rola-Pleszczynski,et al. Rapid in vivo assessment of toxicity of respirable particles: a concise report. , 1983, Research communications in chemical pathology and pharmacology.
[12] M. Rola-Pleszczynski,et al. Asbestos-induced lung injury in the sheep model: the initial alveolitis. , 1983, Environmental research.
[13] M. Rola-Pleszczynski,et al. Clinical features to stage alveolitis in asbestos workers. , 1985, American journal of industrial medicine.
[14] R. Crystal,et al. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. , 1982, The Journal of clinical investigation.
[15] M. Rola-Pleszczynski,et al. Selective exposure and analysis of the sheep tracheal lobe as a model for toxicological studies of respirable particles. , 1985, Environmental research.
[16] R. Crystal,et al. Role of fibronectin as a growth factor for fibroblasts , 1983, The Journal of cell biology.
[17] V Timbrell,et al. UICC standard reference samples of asbestos , 1968, International journal of cancer.
[18] K. Cutroneo,et al. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[19] R. Crystal,et al. Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Adelmann-Grill,et al. Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. , 1981, Thorax.
[21] M. Rola-Pleszczynski,et al. Pulmonary uptake of gallium-67 in asbestos-exposed humans and sheep. , 2015, The American review of respiratory disease.
[22] A. Cantin,et al. Radiographic assessment of pleuropulmonary disease in asbestos workers: posteroanterior, four view films, and computed tomograms of the thorax. , 1984, British journal of industrial medicine.
[23] R. Bégin,et al. Flow and age dependence of airway closure and dynamic compliance. , 1975, Journal of applied physiology.
[24] J. Foidart,et al. Enzyme-linked immunoassay (ELISA) for connective tissue components. , 1980, Analytical biochemistry.
[25] R. Timpl,et al. Radioimmunoassay for type III procollagen peptide and its application to human liver disease , 1979, European journal of clinical investigation.